Indication
Refractory Anemia With Excess Blasts in Transformation
1 clinical trial
3 products
3 drugs
Clinical trial
Hematopoietic Cell Transplantation in the Treatment of Infant Leukemia and Myelodysplastic SyndromeStatus: Recruiting, Estimated PCD: 2025-12-01
Drug
FilgrastimDrug
busulfanProduct
cyclosporineProduct
FludarabineProduct
melphalan